Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Neuroscience Journal
|
July 6, 2019
Sequential Changes in Brain Glutamate and Adenosine A1 Receptors May Explain Severity of Adolescent Alcohol Withdrawal after Consumption of High Levels of Alcohol
Patrycja Bolewska, Bryan I Martin, Krystal A Orlando, et al.
Current Opinion in Structural Biology
|
July 5, 2021
The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer
Elizabeth M Martin, Krystal A Orlando, Kosuke Yokobori, et al.
Expert Review of Anticancer Therapy
|
April 16, 2019
Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
Krystal A Orlando, Vinh Nguyen, Jesse R Raab, et al.
The Journal of Pathology
|
April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type
Yemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines
Marc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics
|
September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Yemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Iscience
|
February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type
Jessica D Lang, William Selleck, Shawn Striker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
Jessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
Cancer Research
|
May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Elizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Neuroscience Journal
|
July 6, 2019
Sequential Changes in Brain Glutamate and Adenosine A1 Receptors May Explain Severity of Adolescent Alcohol Withdrawal after Consumption of High Levels of Alcohol
Patrycja Bolewska, Bryan I Martin, Krystal A Orlando, et al.
Current Opinion in Structural Biology
|
July 5, 2021
The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer
Elizabeth M Martin, Krystal A Orlando, Kosuke Yokobori, et al.
Expert Review of Anticancer Therapy
|
April 16, 2019
Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
Krystal A Orlando, Vinh Nguyen, Jesse R Raab, et al.
The Journal of Pathology
|
April 27, 2017
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type
Yemin Wang, Shary Yuting Chen, Anthony N Karnezis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines
Marc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Molecular Cancer Therapeutics
|
September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Yemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Iscience
|
February 5, 2025
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type
Jessica D Lang, William Selleck, Shawn Striker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
Jessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
Cancer Research
|
May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Elizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
Page
of 1